Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer
Closed
Phase 1
This trial is looking at adding tolinapant to chemoradiotherapy to improve treatment for cancer of the cervix.
Recruitment start: 23 September 2022
Recruitment end: 31 January 2025
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hoskin
ASTEX Pharmaceuticals
Cancer Research UK Combination Alliance
University Hospital Southampton NHS Foundation Trust
Southampton Clinical Trials Unit
University of Manchester
Last reviewed: 31 Jan 2025
CRUK internal database number: 19442
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
